Oral cholestyramine formulation and use thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10786529
APP PUB NO 20170224720A1
SERIAL NO

15449779

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to an oral formulation for targeted delivery of cholestyramine to the colon, comprising a plurality of cholestyramine pellets that are coated with a diffusion-controlled inner coating and an enteric outer coating. The invention also relates to the use of this formulation in the treatment of bile acid malabsorption.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ALBIREO ABARVID WALLGRENS BACKE 20 413 46 GÖTEBORG

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Elversson, Jessica Dalby, SE 21 442
Gillberg, Per-Göran Mölndal, SE 69 1949
Gustafsson, Nils Ove Löddeköpinge, SE 26 492
Lindberg, Nils-Olof Limhamn, SE 30 525

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 29, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 29, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00